Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR)
PaperCitations, authors & open-access status
Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 84 citations, 2018 year and hybrid oa status.
84
Citations
2018
Year
hybrid
OA Status